XML 56 R45.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment Information (Sales And Other Financial Information By Business Segment) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Segment Reporting Information [Line Items]        
Net sales $ 4,479 $ 4,160 $ 13,247 $ 12,407
Segment operating income 808 574 2,027 1,765
Amortization of intangible assets (159) (144) (469) (474)
Recall-related matters 4 (16) (14) (98)
MedSurg and Neurotechnology:        
Segment Reporting Information [Line Items]        
Net sales 2,588 2,349 7,560 6,899
Orthopaedics and Spine:        
Segment Reporting Information [Line Items]        
Net sales 1,891 1,811 5,687 5,508
Operating Segments        
Segment Reporting Information [Line Items]        
Segment operating income 1,145 1,163 3,486 3,518
Operating Segments | MedSurg and Neurotechnology:        
Segment Reporting Information [Line Items]        
Net sales 2,588 2,349 7,560 6,899
Segment operating income 626 663 1,838 2,000
Operating Segments | Orthopaedics and Spine:        
Segment Reporting Information [Line Items]        
Net sales 1,891 1,811 5,687 5,508
Segment operating income 519 500 1,648 1,518
Corporate and other        
Segment Reporting Information [Line Items]        
Segment operating income (144) (105) (488) (421)
Segment Reconciling Items        
Segment Reporting Information [Line Items]        
Acquisition and integration-related costs 78 (126) (108) (495)
Amortization of intangible assets (159) (144) (469) (474)
Restructuring-related and other charges (58) (178) (229) (209)
Medical device regulations (38) (27) (98) (72)
Recall-related matters 4 (16) (14) (98)
Regulatory and legal matters $ (20) $ 7 $ (53) $ 16